News


NEWS


NEWS

SilkTech Gives Interns the Freedom to Think for Themselves

October 4, 2019

SilkTech completes patient enrollment for their Phase 2B clinical trial the use of SDP-4 in treating the signs and symptoms of Dry Eye Disease

July 15, 2019

Press Release: SilkTech Biopharmaceuticals Completes Enrollment of Phase 2B Clinical Trial of SDP-4 for the Treatment of the Signs and Symptoms of Dry Eye Disease

July 15, 2019

SilkTech Biopharmaceuticals will be attending OIS@ASCRS

April 26, 2019

SilkTech’s head of R&D, Dr. David Infanger, will be presenting new research at ARVO 2019 in Vancouver, BC.

April 24, 2019

SilkTech announces IND clearance from FDA for the SDP-4 eye drop and initiates a Phase 2B clinical trial for patients with Dry Eye Disease.

April 17, 2019

US Army awards $537,000 to SilkTech to support clinical development of SDP-4 eye drop product

April 1, 2019

SilkTech forms Medical Advisory Board with world-leading clinicians in both Ophthalmology and Optometry.

February 18, 2019

SilkTech Biopharmaceuticals to present at the inaugural OIS@SECO meeting in New Orleans, LA.

January 28, 2019

Defense Health Agency (DHA) awards $500,000 to SilkTech to support SDP-4 eye drop analytical test method development work.

November 13, 2018

SilkTech’s CEO, Dr. Brian Lawrence, to present at the 10th annual OIS@AAO conference in Chicago, IL.

October 23, 2018

SilkTech to attend OIS@AAO 2018 conference in Chicago, IL.

April 2, 2018

SilkTech issued patent from USPTO for the use of their novel SDP material in ophthalmic formulations.

March 6, 2018

Collaborative in vivo corneal research on Silk-Derived Protein (SDP) published with Weill Cornell Medical College, University of Illinois – Chicago, and SilkTech in the scientific journal PLoS ONE.

November 20, 2017

World recognized leaders in Ophthalmology, Dr. Emmett Cunningham Jr. and Dr. Paul Karpecki, have joined SilkTech’s Board of Directors.

November 16, 2017

Skyview Capital makes significant investment in SilkTech with Series A venture round.

November 8, 2017

SilkTech to attend OIS@AAO 2017 conference in New Orleans, LA.

November 6, 2017

US Army awards $1,000,000 to SilkTech to support development of the company’s flagship SDP-4 biologic drug candidate.

September 18, 2017

Research on studying Silk-Derived Protein (SDP) on in vitro corneal models co-published with Weill Cornell Medical College, University of Illinois – Chicago, and SilkTech in the leading vision research journal IOVS.

March 1, 2017

US Army awards $150,000 to SilkTech to support R&D efforts into exploring the potential ocular healing attributes of the company’s Silk-Derived Protein (SDP) material.

December 22, 2016

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.